100.00% -11.00

Evoke Pharma Inc (EVOK)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Evoke Pharma Inc Stock (EVOK) Company Profile

Evoke Pharma Inc

Healthcare (1114)

858-345-1494

420 STEVENS AVENUE, SOLANA BEACH, CA

Prossima data di guadagno

Ultimi documenti SEC

EVOK's Discussions on Twitter

Confronta EVOK con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
EVOK Evoke Pharma Inc	0.00	18.95M	8.62M	-6.15M	-5.32M	-11.03
ZTS Zoetis Inc	127.17	55.90B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	16.31	51.72B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	9.91	44.71B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	32.01	37.30B	16.88B	666.71M	251.19M	0.6132
RGC Regencell Bioscience Holdings Ltd	45.79	20.48B	0	-5.87M	-767.30K	-0.45

Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2020-06-22	Aggiornamento	H.C. Wainwright	Neutral → Buy
2019-03-05	Downgrade	H.C. Wainwright	Buy → Neutral
2018-03-08	Reiterato	B. Riley FBR, Inc.	Buy
2017-10-19	Ripresa	FBR & Co.	Buy
2017-03-16	Reiterato	Rodman & Renshaw	Buy
2017-01-30	Aggiornamento	Laidlaw	Neutral → Buy
2017-01-05	Aggiornamento	Rodman & Renshaw	Neutral → Buy
2016-12-23	Reiterato	Rodman & Renshaw	Neutral
2016-07-19	Reiterato	FBR Capital	Outperform
2016-07-19	Downgrade	Noble Financial	Buy → Hold
2016-07-18	Downgrade	Rodman & Renshaw	Buy → Neutral
2016-03-16	Iniziato	Northland Capital	Outperform
2016-03-14	Reiterato	Ascendiant Capital Markets	Buy
2016-02-17	Ripresa	FBR Capital	Outperform
2014-12-03	Reiterato	MLV & Co	Buy
2014-11-07	Iniziato	MLV & Co	Buy
2014-04-22	Iniziato	Laidlaw	Buy
2013-11-19	Iniziato	Aegis Capital	Buy

Mostra tutto

Evoke Pharma Inc Borsa (EVOK) Ultime notizie

Evoke Pharma Inc Azioni (EVOK) Dati Finanziari

Evoke Pharma Inc (EVOK)

Evoke Pharma Inc Stock (EVOK) Company Profile

Confronta EVOK con altri titoli

Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades

Evoke Pharma Inc Borsa (EVOK) Ultime notizie

Evoke Pharma Leads Micro-Cap Stocks with 137.07% Return Over Past Year - MarketsMojo

Evoke Pharma Leads Micro-Cap Stocks with 149.43% Return Over Past Year - MarketsMojo

Evoke Pharma Achieves 304.41% Return, Leading Micro-Cap Stock Performance - MarketsMojo

Will Evoke Pharma Inc. stock benefit from commodity prices2025 AllTime Highs & Low Risk High Win Rate Picks - ulpravda.ru

Evoke Pharma Achieves 313.53% Return Amid Mixed Micro-Cap Performance - MarketsMojo

What technical charts say about Evoke Pharma Inc. stock - ulpravda.ru

Will Evoke Pharma Inc. stock keep outperforming rivalsJuly 2025 Fed Impact & Daily Risk Controlled Trade Plans - ulpravda.ru

Will Evoke Pharma Inc. stock gain from strong economyWeekly Profit Analysis & High Accuracy Trade Alerts - ulpravda.ru

Why Evoke Pharma Inc. stock is considered a top pickEarnings Trend Report & Fast Entry High Yield Stock Tips - ulpravda.ru

How Evoke Pharma Inc. stock performs in rate cut cyclesWeekly Trade Summary & Capital Efficiency Focused Strategies - ulpravda.ru

How Evoke Pharma Inc. stock performs in stagflationTrade Analysis Report & Stepwise Swing Trade Plans - ulpravda.ru

Evoke Pharma, Inc.Common Stock (NQ: EVOK - FinancialContent

How Evoke Pharma Inc. stock performs after earningsSwing Trading Watchlist & Free Strong Return On Assets - ulpravda.ru

Evoke Pharma Leads Pharmaceuticals Sector with 137.07% Annual Return - MarketsMojo

Operating cash flow per share of Evoke Pharma, Inc. – SWB:EV0 - TradingView — Track All Markets

Evoke Pharma Achieves 304.41% Return Amid Strong Market Performance - MarketsMojo

Evoke Pharma Achieves 313.53% Return; InnovAge Holding Up 31.39% - Markets Mojo

Evoke Pharma Achieves 313.53% Return Amid Market Volatility - Markets Mojo

Evoke Pharma Leads with 124.95% Return Among Notable Stock Performers - Markets Mojo

Evoke Pharma Leads Stock Performance with 148.87% Return in Pharmaceuticals Sector - Markets Mojo

Evoke Pharma Leads with 148.87% Return Among High-Performing Stocks - MarketsMojo

Bank Watch: Will Evoke Pharma Inc stock gain from strong economyQuarterly Earnings Report & Smart Allocation Stock Reports - moha.gov.vn

Evoke Pharma Leads Impressive Stock Returns with 126.34% Gain - MarketsMojo

Evoke Pharma Achieves 318.7% Return, Leading Pharmaceutical Stocks Performance - MarketsMojo

Evoke Pharma Leads Six-Month Stock Returns with 316.67% Gain - Markets Mojo

Evoke Pharma Achieves 316.67% Return, Leading Pharmaceutical Sector Performance - MarketsMojo

Evoke Pharma, Inc. Financial Disclosures & Filings - TradingView — Track All Markets

Evoke Pharma Leads Stocks with 124.49% Return in Pharmaceuticals Sector - Markets Mojo

Evoke Pharma Leads Six-Month Stock Returns with 298.55% Gain - MarketsMojo

Evoke Pharma Achieves 340% Return, Leading Recent Stock Performers - MarketsMojo

Evoke Pharma Leads Stock Returns with 121.77% Gain Over Past Year - MarketsMojo

Evoke Pharma Leads Stock Performance with 100.36% Return in Past Year - MarketsMojo

Evoke Pharma Leads Six-Month Stock Performance with 303.23% Return - MarketsMojo

Why Evoke Pharma Inc. stock attracts global investorsMarket Trend Summary & Verified Technical Signals - Улправда

Is Evoke Pharma Inc. stock dividend yield sustainable2025 Key Highlights & Community Consensus Trade Alerts - Улправда

Can Evoke Pharma Inc. stock sustain revenue growthAnalyst Downgrade & Low Risk Investment Opportunities - Улправда

Aug Sentiment: Is Evoke Pharma Inc. stock dividend yield sustainable2025 Pullback Review & High Yield Equity Trading Tips - Улправда

Can Evoke Pharma Inc. stock hit analyst price targetsWeekly Trade Recap & Proven Capital Preservation Methods - DonanımHaber

Evoke Pharma Leads Stock Performance with 150% Return in Past Year - Markets Mojo

Evoke Pharma Leads Six-Month Stock Performance with 296.4% Return - Markets Mojo

Will Evoke Pharma Inc. stock benefit from infrastructure spendingJuly 2025 Snapshot & Weekly High Return Opportunities - Улправда

Is Evoke Pharma Inc. stock trading near support levels2025 Trading Volume Trends & Community Driven Trade Alerts - Улправда

Evoke Pharma and QOL Medical Announce Expiration of Tender Offer - BioSpace

Evoke Pharma acquired by QOL Medical, shares to be delisted from Nasdaq - Investing.com Canada

Evoke Pharma (NASDAQ: EVOK) clears shelf registrations following QOL Medical deal - Stock Titan

Evoke Pharma (EVOK) deregisters unsold securities following QOL Medical merger - Stock Titan

Evoke Pharma Inc Azioni (EVOK) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a EVOK